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Adrenocorticotropin hormone (ACTH) produced by the anterior pituitary stimulates
glucocorticoid synthesis by the adrenal cortex. The first step in glucocorticoid synthesis
is the delivery of cholesterol to the mitochondrial matrix where the first enzymatic reaction
in the steroid hormone biosynthetic pathway occurs. A key response of adrenal cells to
ACTH is activation of the cAMP-protein kinase A (PKA) signaling pathway. PKA activation
results in an acute increase in expression and function of the Steroidogenic Acute
Regulatory protein (StAR). StAR plays an essential role in steroidogenesis- it controls
the hormone-dependent movement of cholesterol across the mitochondrial membranes.
Currently StAR’s mechanism of action remains a major unanswered question in the field.
However, some insight may be gained from understanding the mechanism(s) controlling
the PKA-dependent phosphorylation of StAR at S194/195 (mouse/human StAR), a
modification that is required for function. This mini-review provides a background on
StAR’s biology with a focus on StAR phosphorylation. The model for StAR translation and
phosphorylation at the outer mitochondrial membrane, the location for StAR function, is
presented to highlight a unifying theme emerging from diverse studies.
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STAR (STARD1) DISCOVERY AND FUNCTION
The study of steroid hormone production has origins in work on adrenocorticotropin hormone
(ACTH)-stimulated adrenal steroid synthesis (Macchi and Hechter, 1954a,b,c; Stone and Hechter,
1954). ACTH binds to its cognate 7-transmembrane G-protein coupled receptor, the melanocortin
2 receptor (encoded by the MC2R gene) that is located at the plasma membrane of adrenal
fasciculata cells. ACTH binding to MC2R results in activation of multiple signal transduction
pathways with the cAMP-dependent protein kinase A (cAMP-PKA) pathway being central to
hormone-dependent activation of adrenal glucocorticoid and androgen synthesis (reviewed in
Gallo-Payet and Payet, 2003; Spat et al., 2016). All steroid hormones are produced from cholesterol
and the steroidogenic enzymes in cortisol synthesis, themajor adrenal steroid produced in response
to ACTH, have been reviewed in detail (Miller and Auchus, 2011). This mini-review focuses on
the rapid or acute response to tropic hormonal stimulation- the movement of cholesterol into
mitochondria. The first enzymatic reaction is the conversion of cholesterol to pregnenolone by the
cytochrome P450 side chain cleavage enzyme (P450scc). P450scc is located in the mitochondrial
matrix and work from the 1950s–1970s laid a solid foundation that cholesterol transport into
mitochondria for access to P450scc was a key control point in steroidogenesis (Ferguson, 1962,
1963). The prevailing model at that time was that de novo synthesis of a protein factor upon
hormonal stimulation was necessary for the cholesterol transfer. Furthermore, this factor needed
to fulfill the following criteria: be newly synthesized upon hormonal stimulation in a time- and
dose-dependent manner, be localized at the mitochondria, and have a short-half (reviewed in
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Clark and Stocco, 2014; Stocco et al., 2016). Here, I will highlight
the studies which demonstrated that the Steroidogenic Acute
Regulatory protein (StAR) fulfills the criteria for the acute
regulator of steroidogenesis.
The first characterization of StAR was as phosphoproteins (pp
with MW in kDa) pp37, pp32, and pp30 that appeared in rat
adrenal after ACTH stimulation (Krueger and Orme-Johnson,
1983; Pon and Orme-Johnson, 1986; Pon et al., 1986; Alberta
et al., 1989; Epstein and Orme-Johnson, 1991). Both in vivo
and cell culture approaches provided strong correlative data that
ACTH-cAMP-PKA induction of these proteins coincided with
steroid production. In addition, the proteins were shown to be
associated with mitochondria, and the pp32 and pp30 forms
were processed forms of pp37 (Alberta et al., 1989; Epstein and
Orme-Johnson, 1991; Krueger and Orme-Johnson, 1983; Pon
and Orme-Johnson, 1986; Pon et al., 1986). Similar hormonal
responsive protein(s) were characterized in the MA-10 mouse
Leydig tumor cells, and ultimately the StAR protein was purified
and cDNA cloned from this cell line (Clark et al., 1994). The
deduced amino acid sequence encodes a protein with estimated
molecular weight of 31.6 kDa with the amino-terminal region
containing a classical mitochondrial targeting sequence (Clark
et al., 1994). Expression of the cDNA in steroidogenic cells or
in vitro in the presence of isolated mitochondria followed by
Western blot analysis confirmed the cDNA encoded the pp37
protein previously characterized (Clark et al., 1994; King et al.,
1995; Lin et al., 1995). The cDNA encoded a functional protein
based on assays that measured increased steroid production in
COS-1 cells or steroidogenic cells after transient expression of the
cDNA. As anticipated, the 37 kDa StAR protein was imported
and processed by mitochondria to generate the 30 kDa StAR
protein (King et al., 1995). However, steroidogenesis ceases with
removal of tropic hormone stimuli yet the 30 kDa form of StAR
localized in themitochondrial matrix is present with an estimated
half-life of 4–5 h (Stocco and Sodeman, 1991; Granot et al.,
2003). Thus, the requirement for a labile, short half-life criteria
for the acute regulator of steroidogenesis required subsequent
structure-function studies. Database searches using the cDNA
and protein sequences revealed that StAR represented a novel
protein (Clark et al., 1994). Shortly after the initial reports on
StAR appeared, a conserved protein domain named the START
domain (for steroidogenic acute regulatory protein (StAR)-
related lipid-transfer domain), was identified using Web-based
resources for predicting putative functional domains based on
primary sequence data (Ponting and Aravind, 1999). Members
of the START domain protein superfamily share a 210 amino
acid region that folds into an α/β helix-grip fold structure
containing a long hydrophobic cleft for lipid binding (reviewed in
Stocco, 2001; Clark, 2012). The START domain within the StAR
protein spans amino acids 65–285, which encodes the processed
30 kDa form, and binds cholesterol. Key studies showed that
only the START domain is required for StAR’s function: (1)
addition of the 30 kDa StAR protein to isolated mitochondria
promotes cholesterol transfer and pregnenolone production; and
(2) expression of a cDNA encoding only the START domain,
e.g., lacking the N-terminal mitochondrial targeting sequence
(N62StAR), is capable of stimulating steroid production in
steroidogenic cells or heterologous COS-1 cells (Arakane et al.,
1996; Wang et al., 1998). Furthermore, mutations in the human
STAR gene (STARD1) were identified in patients with congenital
lipoid adrenal hyperplasia (lipoid CAH), a disorder marked
by a lack of adrenal and gonadal steroidogenesis due to the
inability to move cholesterol into the mitochondria [(Lin et al.,
1995; Bose et al., 2000); reviewed in (Miller, 2014)]. The finding
that STAR mutations are the genetic basis for lipoid CAH
was key to establishing the essential role for StAR in ACTH-
stimulated steroidogenesis as well as gonadotropin-stimulated
steroidogenesis (Lin et al., 1995; Caron et al., 1997). A common
mutation found in the STAR gene is a nonsensemutation, Q258X,
which results in truncation of the last 28 amino acids (Nakae
et al., 1997; Kim et al., 2011). Expression of C-terminal truncated
forms of StAR in COS-1 cells confirmed that the loss of C-
terminal helix, within the START domain, results in an inactive
protein (Arakane et al., 1996; Wang et al., 1998).
The finding that N-terminal truncated StAR (N62StAR) was
functional in cell-based assays, indicated that mitochondrial
import was not required for function. However, the targeting of
StAR to mitochondria may be important for efficient cholesterol
transfer and steroid production in vivo. A mouse model of
lipoid CAH was generated by “knocking out” StAR expression
and, as anticipated, the animals lacked steroid production and
significant amounts of cholesterol accumulated in the adrenals
and gonads (Caron et al., 1997). Expression of a full-length
STAR transgene in the StAR knockout mice restored adrenal
and gonadal steroidogenesis while expression of the N62STAR
transgene only partially restored steroidogenesis in a tissue- and
gender-specific manner (Sasaki et al., 2008). The mice with the
N62StAR transgene retained modest lipid accumulation in the
adrenal and gonads. These data support that StAR is capable
of functioning without the N-terminal mitochondrial targeting
sequence, but highlight the importance of correct and efficient
subcellular localization of the protein for full function in vivo.
In the absence of mitochondrial import, N62StAR still associates
with mitochondria outer membrane (Arakane et al., 1996; Wang
et al., 1998).
STAR PHOSPHORYLATION AND
FUNCTION
Early studies proposed an association between StAR
phosphorylation and function (Pon et al., 1986; Chaudhary
and Stocco, 1991; Clark et al., 1995; Hartigan et al., 1995).
A PKA-dependent phosphorylation at S194 (mouse) or S195
(human) was validated as an important post-translational
modification required for StAR’s function in cell-based and in
vitro assays (Arakane et al., 1996; Jo et al., 2005; Baker et al.,
2007). StAR-S194/195 nomenclature reflects the deletion of
3 nucleotides in exon 2 that eliminates a residue which lies
within the cleavable mitochondrial signal sequence in mouse
StAR. A key study confirmed the relevance for StAR-S194
phosphorylation in vivo; StAR knock-out mice were used to
demonstrate that re-expression of wild-type StAR but not
StAR-S194A restored steroidogenesis in the adrenal and testis
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(Sasaki et al., 2014). The newborn StAR-S194A transgenic male
mice had lipid accumulation in the adrenal and testis, and
circulating hormone levels (high ACTH and low corticosterone
and testosterone) similar to StAR knock-out mice. Thus, StAR
phosphorylation at S194/195 is critical for function in vivo.
The molecular mechanism of action for StAR-mediated
cholesterol transport across the mitochondrial membranes is not
fully defined, therefore it remains a challenge to define the role of
S194/195 phosphorylation in StAR’s function. The current model
for StAR-mediated cholesterol transport asserts that protein-
protein interactions between StAR and OMM protein(s) triggers
cholesterol transfer (Bose et al., 1999; Mathieu et al., 2002;
Baker et al., 2007; Roostaee et al., 2008; Rajapaksha et al., 2013).
Structural changes in the START domain induced by cholesterol
binding and by interaction with the OMM as well as the kinetics
of cholesterol transfer across the mitochondrial membranes
have been reviewed elsewhere (Miller, 2007). Precursor StAR
processing to the mitochondrial 30 kDa form is reported to be
very efficient, stoichiometric, and dependent upon cholesterol-
induced structural changes (Artemenko et al., 2001; Rajapaksha
et al., 2013). Import of StAR is proposed to be the “off switch”
for cholesterol transfer due to loss of StAR interaction with
an OMM protein complex (Bose et al., 1999; Miller, 2007).
However, the transit time at the OMM contributes to StAR
function with slower mitochondrial import associated with
greater activity (Bose et al., 2002). Does StAR phosphorylation
affect cholesterol binding or mitochondrial import? Purified
hStAR START domain containing the S195A mutation was
shown to have the same cholesterol binding kinetics as wild-
type StAR START domain, indicating that phosphorylation is
not required for cholesterol binding (Baker et al., 2007). StAR-
S194A/S195A or non-phosphorylated forms of wild-type StAR
are efficiently processed to the 30 kDamitochondrial matrix form
both in cell culture and in vivo studies, thus phosphorylation
doesn’t appear necessary for StAR import (Arakane et al., 1997;
Jo et al., 2005; Sasaki et al., 2014; Clark and Hudson, 2015). The
region that slows StAR import is a protease-resistant domain that
spans amino acids 63–188 (Bose et al., 1999, 2002), therefore, it is
unlikely that S194/195 phosphorylation alters StAR import rates,
although this has not been directly tested.
While StAR phosphorylation doesn’t appear to be required
for mitochondrial import, understanding the import mechanism
may provide insight into StAR-OMM interactions that are
required for function. TOM20 and TOM22 are the receptor
components of the Translocase of the outer membrane (TOM)
complex that function with the pore-forming TOM40 complex
to control protein import into mitochondria (Becker et al., 2012;
Harbauer Angelika et al., 2014). Classically, post-translational
protein import via a TOM20/22-TOM40 pathway is associated
with proteins that are synthesized in the cytoplasm with a
cleavable amino-terminal amphipathic helix that serves as a
mitochondrial matrix targeting sequence, such as StAR (reviewed
in Harbauer Angelika et al., 2014, Figure 1). The proteins are
in complex with chaperones to maintain an unfolded state for
import while the amino terminal sequence binds TOM20/22
receptors (Harbauer Angelika et al., 2014). However, a co-
translational mechanism for import of matrix-localized proteins
with amino-terminal cleavable signal sequences was proposed
over 40 years ago (Kellems et al., 1974) and recent data in yeast
support thismodel. mRNAs co-purify with isolatedmitochondria
in wild-type yeast strains but not TOM20 deficient strains
following cycloheximide (CHX) treatment (Eliyahu et al., 2010).
These data indicate that blocking translation and stabilizing
polysomes by CHX enhances ribosome-mRNA interactions with
mitochondria in a TOM20-dependent manner. StAR has been
shown to co-purify with TOM22 and siRNA knock-down
of TOM22 in MA-10 cells results in diminished cholesterol
metabolism by isolated mitochondria (Prasad et al., 2015, 2016).
Since the StAR import mechanism is incompletely described,
I use TOM20/22 to reflect both receptors work together for
preprotein import in the classical mitochondrial import model.
However, it may be that TOM20 and TOM22 can serve
redundant functions for StAR import while TOM22 is required
for StAR function (Rajapaksha et al., 2013, 2016).
Localized translation and post-translational modification of
StAR at the mitochondria is an attractive model for the acute
control of steroidogenesis (Dyson et al., 2008; Eliyahu et al.,
2010; Lesnik et al., 2015). This model is supported by data that
show StAR mRNA was associated with mitochondrial A-kinase
anchoring protein 121 (AKAP121) and type II PKA in MA-
10 mouse Leydig cells (Dyson et al., 2008, 2009). Independent
studies have also demonstrated a PKA-dependent co-localization
of AKAP121, acyl-CoA, and upstream ERK1/2 kinases with StAR
at the mitochondria (reviewed in Poderoso et al., 2009; Paz et al.,
2016). Thus, the co-localization of PKA andAKAP proteins at the
mitochondria is emerging as a consistent theme. siRNA-mediated
silencing of AKAP121 in MA-10 Leydig cells resulted in loss
of PKA (PKAR2) association with mitochondria, independent
of Bt2cAMP treatment, indicating that an AKAP121-PKAR2
complex is constitutively poised at the OMM (Dyson et al., 2008).
Immunofluorescence-based detection of AKAP1 in H295R
human adrenocortical cell line showed co-localization with
TOM20, indicating localization with mitochondria in an adrenal
cell line (Grozdanov and Stocco, 2012). Furthermore, a portion
of StAR 3′UTR mRNA was shown to directly bind to AKAP1
and in H295R cells and StAR mRNA was recovered following
AKAP1 immunoprecipitation (Grozdanov and Stocco, 2012).
The StAR mRNA-AKAP1 interaction was detected only after
Bt2cAMP treatment of H295R cells suggesting that newly
transcribed StAR mRNA associates with AKAP1. Our earlier
work demonstrated that StAR mRNA levels and endogenous
protein levels are greatly diminished in the PKA deficient
mouse Kin-8 adrenocortical cells following Bt2cAMP treatment
compared to the PKA responsive Y1 adrenocortical cells (Clark
et al., 1997; Clark and Hudson, 2015). Yet despite the lower
StAR mRNA levels, the mRNA was associated with actively
transcribing ribosomes and StAR protein synthesis rates were
the same in both cell lines, indicating translation is intact in
the absence of PKA signaling (Clark and Hudson, 2015; Clark
et al., 1997). Conversely, in MA-10 cells that lack AKAP1
via siRNA-mediated silencing, Bt2cAMP treatment increased
StAR steady-state mRNA levels but StAR protein levels were
diminished. Together the data support that newly transcribed
StARmRNA associates with AKAP1 in adrenocortical cells (Kin8
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FIGURE 1 | Model for localized StAR translation and phosphorylation at mitochondria. The TOM20/22-40 complex is an established pathway for import of
matrix-localized proteins that contain an N-terminal cleavable signal peptide. StAR is modeled within this import pathway, although the import pathway for StAR
remains to be determined. The ribosome nascent chain complex (RNC) is shown as StAR mRNA bound by the ribosome and protein depicted as black line with the
N-terminus denoted (N). The START domain is depicted by the “folded” black line. StAR translation is modeled on both free ribosomes (steps c and d) and
mitochondria-associated ribosomes (steps a to b or a’ to b’) as described in the text. Cleavage of the N-terminal signal sequence by matrix metalloproteases
(indicated by the thunderbolt) produces the 30 kDa STAR protein (START domain) in the matrix. The import of StAR is the “off switch” for cholesterol transfer due to
loss of interaction with an OMM protein complex. The OMM protein complex (indicated here as a green rectangle) that facilitates the StAR-dependent cholesterol
transfer from the OMM to the matrix remains to be determined. Proposed OMM components of this complex include StAR, AKAP, PKA, VDAC1/2, TOM22, PCP,
TSPO, and ACBD3. The OMM protein that interacts specifically with phosphoStAR to trigger complex formation for cholesterol transfer across the mitochondrial
membranes remains to be identified. TIM (Translocase of the inner membrane) complex; IMS, intermembrane space; OMM, outer mitochondrial membrane; IMM,
inner mitochondrial membrane. Concepts of this model have been presented by others in Dyson et al. (2008), Poderoso et al. (2009), Grozdanov and Stocco (2012),
Aghazadeh et al. (2015), Prasad et al. (2015), Lee et al. (2016b), Midzak and Papadopoulos (2016), and Paz et al. (2016).
and H295R cells) and that the AKAP1-StAR mRNA association
contributes to translation efficiency. The model that AKAP1
localizes PKAR2 at the OMM provides a platform for localized
phosphorylation of StAR (Grozdanov and Stocco, 2012; Merrill
and Strack, 2014, Figure 1). Recently StAR mRNA association
with mitochondria in MA-10 cells was demonstrated using
high resolution fluorescence in situ hybridization (Lee et al.,
2016a). Key findings from this work indicate that StAR mRNA-
mitochondrial interactions are dynamic, and suggest that when
StAR transcription is maximally activated, newly transcribed
and processed StAR mRNA is delivered to the cytoplasm and
mitochondria for efficient translation.
The prevailing concept is that StAR phosphorylation
influences key interactions with OMM proteins that promote
cholesterol transfer. The challenge is that several StAR-
interacting complexes at the OMM have been proposed
yet the identity of the functional StAR cholesterol transfer
complex remains to be validated (Bose et al., 2008; Rone
et al., 2012; Issop et al., 2015). Early work characterized a
OMM protein complex that included 18 kDa translocator
protein (TSPO) and voltage-dependent anion channels 1
(VDAC1) (Liu et al., 2006). The working model was that
upon hormonal stimulation StAR is expressed and associates
with acyl-coenzyme A binding domain containing 3 protein
(ACBD3), previously referred to as TSPO-associated protein
(PAP7), leading to a StAR-PKA-ACBD3-TSPO-VDAC1 complex
at the OMM (reviewed in Papadopoulos et al., 2015; Midzak
and Papadopoulos, 2016). In vitro studies using mitochondria
isolated from sheep adrenal incubated with radiolabeled,
in vitro synthesized StAR protein identified VDAC1 and
phosphate carrier protein (PCP, SLC25A3) as components
of a StAR-containing complex (Bose et al., 2008). VDAC1,
VDAC2, TOM22, and StAR have been shown to be part of
large multiprotein complexes purified from mitochondria or
mitochondria-associated endoplasmic reticulum (ER)membrane
(MAM) regions isolated from rat testes andMA-10mouse Leydig
tumor cells (Prasad et al., 2015). The functional significance for
these proposed complexes is based on data that demonstrated
siRNA-mediated silencing and/or pharmacological inhibition
of TSPO, VDAC1, VDAC2, or ACBD3 decreased or blocked
cAMP-PKA-mediated steroid production in steroidogenic
cells or StAR-mediated steroid production in COS-1 cells.
However, mouse models lacking either TSPO or VDAC1
expression are viable and fertile (Weeber et al., 2002; Sileikyte
et al., 2014; Tu et al., 2014), although VDAC1−/− mice present
with mitochondrial alterations in a strain-dependent manner.
Loss of VDAC2 results in embryonic lethality (Anflous et al.,
2001; Craigen and Graham, 2008). These studies indicate that
TSPO and VDAC1 are not obligatory for steroidogenesis,
and suggest a redundancy of function for cholesterol transfer
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may occur in the absence of these factors. The question is
whether StAR phosphorylation drives interaction with any of
these OMM proteins. siRNA-mediated silencing of VDAC1 or
PCP protein expression in COS-1 cells resulted in decreased
vector-driven StAR protein levels with a corresponding decrease
in phosphoStAR levels and steroidogenic response (Bose
et al., 2008). The 30 kDa StAR was detected by Western blot
analysis indicating that mitochondrial import of StAR was
intact in VDAC1 null cells. However, 30 kDa phosphoStAR
was greatly diminished indicating that in the absence of
VDAC1, import of phosphorylated StAR into mitochondria was
blocked. Addition of cysteine protease inhibitors to the VDAC1
deficient cells restored StAR phosphorylation and phosphoStAR
mitochondrial import and steroid production to levels observed
in control cells (Bose et al., 2008). One interpretation of these
data is that VDAC1 may help stabilize precursor StAR allowing
for StAR phosphorylation and enhanced cholesterol transport
function. In a separate study, COS-1 cells with siRNA-mediated
loss of VDAC2 expression retained vector-driven StAR synthesis
and phosphorylation but there was no steroidogenic response
(Prasad et al., 2015). In the absence of VDAC2, as with
VDAC1, no mitochondrial import of phosphoStAR was detected
(unphosphorylated StAR was not measured) (Prasad et al., 2015).
Furthermore, a StAR-VDAC2 complex was immunoprecipitated
from COS-1 cells overexpressing VDAC2 and N62StAR,
providing the first evidence for a possible direct interaction
between StAR and an OMM protein (Prasad et al., 2015). These
data suggest that synthesis of phosphorylated precursor StAR
is not sufficient for function, and support a role for specific
phosphoStAR-OMM interactions mediating cholesterol transfer.
The authors propose that StAR is synthesized at MAM regions
and interacts with VDAC2 for subsequent mitochondrial import
and StAR processing (Prasad et al., 2015). Perhaps the loss
of phosphoStAR import in the absence of either VDAC1 or
VDAC2 reflects a loss of StAR’s N-terminal interaction with the
TOM20/22-TOM40 complex, leading to loss of StAR structure
which is necessary for cholesterol transfer function of StAR
(Rajapaksha et al., 2013; Prasad et al., 2015, Figure 1).
In summary, ACTH action on StAR biology requires an
immediate response to hormone stimulation, which is seen
in a rapid increase in StAR transcription. StAR translation,
phosphorylation, and mitochondrial import are likely
coordinated processes, but the mechanisms regulating these
steps are lacking. Nevertheless, the work over the past decade
supports a model for localized translation at the mitochondria.
One proposed scenario is the newly transcribed StAR mRNA
binds AKAP1 through 3′UTR-driven interactions localizing the
mRNA to the mitochondria where it is bound by ribosomes and
translated (Figure 1, step a and b). Alternatively, cytoplasmic
StAR mRNA is bound by ribosomes and the ribosome-nascent-
chain is directed to mitochondria where the interaction is
stabilized by 3′UTR mRNA-AKAP1 interaction, similar to
co-translational models described for yeast (Figure 1, step a’
and b’). StAR mRNA 3′UTR driving mitochondrial location and
localized translation could explain the amino-terminal truncated
form of StAR (N62StAR), which lacks the signal sequence,
being localized to the OMM and functional. Translation of the
amino-terminal mitochondrial signal sequence, on the other
hand, could lead to recognition by the TOM20/22-TOM40
complex, thereby tethering StAR to the TOM complex. StAR
translation continues and phosphorylation of S194/195 of the
START domain occurs in a co-translational process by the
mitochondrial localized PKA. Post-translational mitochondrial
targeting of StAR would follow the classical pathway; StAR is
synthesized on cytoplasmic polysomes, bound by chaperones,
and targeted to TOM20/22 by the N-terminal signal sequence
(Figure 1, steps c and d). StAR phosphorylation could occur
at any step in this classical pathway. In both the co- and post-
translational models, there must be a mechanism allowing for
folding of the START domain and phosphorylation of S194/195
that are necessary for interactions at the OMM that promote
cholesterol transfer. StAR import is slowed by a pause domain
(Bose et al., 1999, 2002), and this could permit time necessary
to generate phosphoStAR by mitochondrial localized PKA.
The retention of phosphoStAR’s START domain at the OMM
signals for cholesterol transfer. Thus, studies directed at testing
StARS194/195-OMM protein interactions may help uncover
the ACTH-dependent phosphoStAR-OMM protein interaction
specific for cholesterol transfer.
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